In various tumor types, METTL3 typically functions as an oncogenic factor, including acute myeloid leukemia (AML), lung cancer, HCC, among others, while exhibiting an anti-oncogenic role in endometrial cancer [32]. This evidence concerns the gene METTL3 and acute myeloid leukemia.